Reporting of cluster randomised crossover trials: extension of the CONSORT 2010 statement with explanation and elaboration

Affiliations

• ¹ Methods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia [email protected].
• ² Clinical Epidemiology Programme, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
• ³ School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
• ⁴ Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
• ⁵ Methods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia.
• ⁶ University of Tours, University of Nantes, INSERM SPHERE U1246, Tours, France.
• ⁷ INSERM CIC, CHRU de Tours, Tours, France.
• ⁸ Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
• ⁹ MRC Clinical Trials Unit at University College London, London, UK.
• ¹⁰ Department of Ophthalmology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
• ¹¹ Centre for Journalology, Clinical Epidemiology Programme, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
• ¹² Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
• ¹³ Duke Global Health Institute, Duke University, Durham, NC, USA.
• ¹⁴ Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
• ¹⁵ Biostatistics Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.